PharmaCyte Biotech

(OTC: PMCB)
Healthcare  |  Biotechnology
0.04 0.0 0.0%
Stock Price | Aug. 19, 2019, 3:56 p.m.
1 Follower
Bid: 0.033
Ask: 0.037
Prev. Close: 0.0352
52 Week Low: 0.0331
52 Week High: 0.0702
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

PharmaCyte Biotech Inc is a clinical stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including advanced, inoperable pancreatic cancer, and diabetes will be developed. It is developing therapies for pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

Read more Read less

Recently Viewed Tickers

Premium A Look at the Laggards in the 420 Investor Cannabis Stock Index

39 Comments
2 years ago

Premium 420 Investor Cannabis Stock Survey

8 Comments
2 years ago

Free Cannabis Stock Survey - Public

2 years ago

Premium Cannabis Stocks Review - Weekend Edition 04/25/16

8 Comments
3 years ago

Premium Cannabis Stocks Review - Weekend Edition 04/18/16

10 Comments
3 years ago

Premium Cannabis Stocks Review - Pre-Market Edition 04/11/16

11 Comments
3 years ago

Premium Cannabis Stocks Review - Weekend Edition 04/04/16

1 Comments
3 years ago

Premium Cannabis Stocks Review - Weekend Edition 03/28/16

14 Comments
3 years ago

Premium Cannabis Stocks Review - Weekend Edition 03/21/16

2 Comments
3 years ago

Premium Cannabis Stocks Review - Weekend Edition 03/14/16

10 Comments
3 years ago